반응형

medical device 117

[Emergo, UL] Current State of UDI in Brazil: Review of RDC 591/2021 and RDC 884/2024

The Normative Instruction to announce the ANVISA UDI database, SIUD, is expected soonBackground on RDC 591/2021The National Health Surveillance Agency or ANVISA (Agência Nacional de Vigilância Sanitária) is the Brazilian regulatory agency responsible for the supervision of food, cosmetics, tobacco, pharmaceuticals, health services, and medical devices. Recently, ANVISA enacted RDC 591/2021, whic..

뉴스 보고서 12:30:49

[Emergo, UL] European Packaging Waste Legislation Repeals the Directive and Applies in Mid-2026

The European legislation on packaging waste (Regulation (EU) 2025/40) was adopted late last year (December 19, 2024) and published in the Official Journal of the European Union (OJEU) in January (January 22, 2025), repealing Directive 94/62/EC. Most provisions start to apply on August 12, 2026. Directive 94/62/EC was concise. Regulation 2025/40 has 188 recitals, 71 definitions, 71 articles, and ..

뉴스 보고서 2025.07.14

[Emergo, UL] Decoding MDCG 2025-6: Interplay between the MDR/IVDR and AIA

If guidance on medical device software (MDSW) were a series, we just got three episodes in one week. Kicking off the triple release was MDCG 2025-4, released on June 16, which tackled the safe deployment of medical device apps on digital platforms. On June 17, a revised MDCG 2019-11 version clarified the qualification and classification of software under MDR/IVDR and introduced the interplay wi..

뉴스 보고서 2025.07.03

[EU] MDCG 2025-4 - Guidance on the safe making available of medical device software (MDSW) apps on online platforms (June 2025)

Introduction Software Applications (Apps) are significantly changing our way of living, helping in various aspects of our daily lives, including healthcare. Medical device software (MDSW) Apps cover an extensive variety of uses such as those intended to drive insulin pumps, detect and diagnose skin cancers (e.g. melanoma) etc. These apps are directly available on app platforms for download and u..

유럽 MDR, IVDR 2025.07.02

[Emergo, UL] European Commission issues guidance on making safer apps available

In our daily lives and also in the medical field, patients and healthcare professionals are increasingly using apps. On June 16, the European Commission (EC) published “MDCG 2025-4 Guidance on the safe making available of medical device software (MDSW) apps on online platforms.” While the EC has published several pieces of guidance on MDSW already (our next update will be on the MDCG 2019-11 rev..

뉴스 보고서 2025.06.30

[EU] Update MDCG 2019-11 rev.1 - Qualification and classification of software - Regulation (EU) 2017/745 and Regulation (EU) 2017/746 (June 2025)

Scope and purpose of this document This document, which primarily targets Medical Device Software (MDSW) manufacturers, provides guidance on:• the criteria for the qualification of software falling within the scope of the Medical Device Regulations, including Medical Device Artificial Intelligence (MDAI),• the application of the classification criteria under those regulations to MDSW and• inform..

유럽 MDR, IVDR 2025.06.27

[EU] MDCG 2025-5 - Questions & Answers regarding performance studies of in vitro diagnostic medical devices under regulation (EU) 2017/746 (June 2025)

Introduction This document is intended for sponsors of performance studies of in vitro diagnostic medical devices (IVDs) conducted within the scope of the Regulation (EU) 2017/746 (IVDR). It also contains information of relevance to manufacturers providing IVDs for use in performance studies that may be sponsored by other actors, and sponsors of combined studies. Throughout this document, the te..

유럽 MDR, IVDR 2025.06.26

[EU, MDCG] MDCG 2025-6 - FAQ on Interplay between the Medical Devices Regulation & In vitro Diagnostic Medical Devices Regulation and the Artificial Intelligence Act (June 2025)

Introduction This document provides a first set of answers, that will be continuously developed and updated, to the most frequently asked questions related to the joint application of the AIA and the MDR or IVDR4 for manufacturers. This Frequently Asked Questions (FAQ) document is primarily aimed at (but not limited to) medical device manufacturers, notified bodies and competent authorities. All..

유럽 MDR, IVDR 2025.06.25
반응형